CAR-T ICU 2019 | Tocilizumab for CAR-T adverse event management

Name: Tocilizumab for CAR-T adverse event management
Uploaded: 2019-07-10T08:41:33.000Z
Duration: 1 min 31 s
Description: Élie Azoulay, PhD, MD, Saint-Louis University Hospital, Paris, France, explains the promising results of CAR T-cell therapy and the use of tocilizumab for the management of potential adverse events. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.

Élie Azoulay • 10 Jul 2019

CAR-T ICU 2019

CAR-T Tocilizumab

Élie Azoulay, PhD, MD, Saint-Louis University Hospital, Paris, France, explains the promising results of CAR T-cell therapy and the use of tocilizumab for the management of potential adverse events. This interview took place at the CAR-T Cell Therapy and the ICU meeting in London, UK, which was organized by EuroCARTForce.